XENE - CIK 0001582313
As of 2026-06-13, Xenon Pharmaceuticals Inc. (XENE) has a market capitalization of $5.04 B, making it the #1402 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-06-13 | $5.04 B |
| 2026-06-12 | $5.06 B |
| 2026-06-11 | $5.01 B |
| 2026-06-10 | $4.96 B |
| 2026-05-29 | $5.31 B |
| 2026-05-28 | $5.21 B |
| 2026-05-26 | $5.26 B |
| 2026-05-25 | $5.24 B |
| 2026-05-24 | $5.24 B |
| 2026-05-22 | $5.24 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
As of 2026-06-13, Xenon Pharmaceuticals Inc. (XENE) has a market capitalization of $5.04 B, making it the #1402 most valuable US-listed company.
Xenon Pharmaceuticals Inc. is the #1402 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.